There is an upregulation in NCOA4 at the peak and progressive stages of experimental MS along with an upregulation in transferrin receptor 1 (TfR1) which enables the uptake of transferrin into cells via receptor-mediated endocytosis, subsequently releasing the iron carried on transferrin into the cellular iron pool. This evidence concerns the gene TF and myeloid sarcoma.